 |
 |
|
Home |
Current Issue |
Past Issues |
In the Clinic |
ACP Journal Club |
CME |
Collections |
Audio/Video |
Mobile |
Subscribe |
Tools |
Help |
ACP Online
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 April 1998 | Volume 128 Issue 7 | Pages 524-533
Background: Categorical definitions for glucose intolerance imply that risk thresholds exist, but metabolic risk for type 2 diabetes mellitus or cardiovascular disease may increase continuously as glucose intolerance increases.
Objective: To examine the distributions of the following metabolic risk factors across the spectrum of glucose tolerance: overall and central obesity, hypertension, low levels of high-density lipoprotein cholesterol, and increased triglyceride and insulin levels.
Design: Cross-sectional analysis.
Setting: The community-based Framingham Offspring Study.
Participants: 2583 adults without previously diagnosed diabetes.
Measurements: Clinical data; fasting glucose, insulin, and lipid levels; and glucose and insulin levels taken 2 hours after oral challenge were collected from 1991 to 1993. Glucose tolerance was determined by 1980 World Health Organization criteria. Patients with normal glucose tolerance were categorized into quintiles of fasting glucose. The distributions of each metabolic risk factor and the metabolic sum of the six risk factors were assessed across seven categories from the lowest quintile of normal fasting glucose level through impaired glucose tolerance and previously undiagnosed diabetes.
Results: The mean age of patients was 54 years (range, 26 to 82 years); 52.7% of patients were women, Glucose tolerance testing found that 12.7% of patients had impaired glucose tolerance and 4.8% had previously undiagnosed diabetes. Multivariable-adjusted mean measures of risk factors and odds ratios for obesity, elevated waist-to-hip ratio, hypertension, low levels of high-density lipoprotein cholesterol, elevated triglyceride levels, and hyperinsulinemia showed continuous increases across the spectrum of nondiabetic glucose tolerance. Although a threshold effect near the upper range of nondiabetic glucose tolerance could not be ruled out for triglyceride levels in men and for insulin levels 2 hours after oral challenge in men and women, no other metabolic risk factors showed clear evidence of thresholds for increased risk.
Conclusions: Metabolic risk factors for type 2 diabetes mellitus and for cardiovascular disease worsen continuously across the spectrum of glucose tolerance categories, beginning in the lowest quintiles of normal fasting glucose level.
Author and Article Information
Grant Support: In part by the Earle P. Charlton, Jr. Charitable Foundation and by a subcontract from the National Heart, Lung, and Blood Institute Framingham Heart Study, National Institutes of Health (NIH/NHLBI contract NO1-HC-38083).
ARTICLE
Metabolic Risk Factors Worsen Continuously across the Spectrum of Nondiabetic Glucose Tolerance: The Framingham Offspring Study
Requests for Reprints: James B. Meigs, MD, MPH, General Medicine Division, Staniford 50-9, Massachusetts General Hospital, Boston, MA 02114; e-mail jmeigs@sol.mgh.harvard.edu.
Current Author Addresses: Drs. Meigs and Singer: General Medicine Division, Staniford 50-9, Massachusetts General Hospital, Boston, MA 02114.
This article has been cited by other articles:
|
|
 |
|
  E. S. Stolerman, A. K. Manning, J. B. McAteer, J. Dupuis, C. S. Fox, L. A. Cupples, J. B. Meigs, and J. C. Florez Haplotype Structure of the ENPP1 Gene and Nominal Association of the K121Q Missense Single Nucleotide Polymorphism With Glycemic Traits in the Framingham Heart Study Diabetes, July 1, 2008; 57(7): 1971 - 1977. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 U.S. Preventive Services Task Force Screening for Type 2 Diabetes Mellitus in Adults: U.S. Preventive Services Task Force Recommendation Statement Ann Intern Med, June 3, 2008; 148(11): 846 - 854. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. L. Norris, D. Kansagara, C. Bougatsos, and R. Fu Screening Adults for Type 2 Diabetes: A Review of the Evidence for the U.S. Preventive Services Task Force Ann Intern Med, June 3, 2008; 148(11): 855 - 868. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. W.F. Wilson and J. B. Meigs Risk of type 2 diabetes mellitus and coronary heart disease: a pivotal role for metabolic factors Eur. Heart J. Suppl., March 1, 2008; 10(suppl_B): B11 - B15. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. C. Florez, A. K. Manning, J. Dupuis, J. McAteer, K. Irenze, L. Gianniny, D. B. Mirel, C. S. Fox, L. A. Cupples, and J. B. Meigs A 100K Genome-Wide Association Scan for Diabetes and Related Traits in the Framingham Heart Study: Replication and Integration With Other Genome-Wide Datasets Diabetes, December 1, 2007; 56(12): 3063 - 3074. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Porrini, M. D. Gomez, A. Alvarez, M. Cobo, J. M. Gonzalez-Posada, L. Perez, L. Hortal, J. J. Garcia, M. Dolores Checa, A. Morales, et al. Glycated haemoglobin levels are related to chronic subclinical inflammation in renal transplant recipients without pre-existing or new onset diabetes Nephrol. Dial. Transplant., July 1, 2007; 22(7): 1994 - 1999. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. J. Fogli-Cawley, J. T. Dwyer, E. Saltzman, M. L. McCullough, L. M. Troy, J. B. Meigs, and P. F. Jacques The 2005 Dietary Guidelines for Americans and Insulin Resistance in the Framingham Offspring Cohort Diabetes Care, April 1, 2007; 30(4): 817 - 822. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. M. Grundy Metabolic Syndrome: Connecting and Reconciling Cardiovascular and Diabetes Worlds J. Am. Coll. Cardiol., March 21, 2006; 47(6): 1093 - 1100. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. A. Armstrong, J. B. Prins, E. M. Beller, S. B. Campbell, C. M. Hawley, D. W. Johnson, and N. M. Isbel Should an Oral Glucose Tolerance Test Be Performed Routinely in All Renal Transplant Recipients? Clin. J. Am. Soc. Nephrol., January 1, 2006; 1(1): 100 - 108. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Prepared by: British Cardiac Society, British Hype JBS 2: Joint British Societies' guidelines on prevention of cardiovascular disease in clinical practice Heart, December 1, 2005; 91(suppl_5): v1 - v52. [Full Text] [PDF]
|
|
|
|
 |
|
 A. H. Lauruschkat, B. Arnrich, A. A. Albert, J. A. Walter, B. Amann, U. P. Rosendahl, T. Alexander, and J. Ennker Prevalence and Risks of Undiagnosed Diabetes Mellitus in Patients Undergoing Coronary Artery Bypass Grafting Circulation, October 18, 2005; 112(16): 2397 - 2402. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. M. Pascual, E. Rodilla, C. Gonzalez, S. Perez-Hoyos, and J. Redon Long-Term Impact of Systolic Blood Pressure and Glycemia on the Development of Microalbuminuria in Essential Hypertension Hypertension, June 1, 2005; 45(6): 1125 - 1130. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. N. Kernan, C. M. Viscoli, S. E. Inzucchi, L. M. Brass, D. M. Bravata, G. I. Shulman, and J. C. McVeety Prevalence of Abnormal Glucose Tolerance Following a Transient Ischemic Attack or Ischemic Stroke Arch Intern Med, January 24, 2005; 165(2): 227 - 233. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. R. Blake, J. B. Meigs, D. C. Muller, S. S. Najjar, R. Andres, and D. M. Nathan Impaired Glucose Tolerance, but not Impaired Fasting Glucose, Is Associated With Increased Levels of Coronary Heart Disease Risk Factors: Results From the Baltimore Longitudinal Study on Aging Diabetes, August 1, 2004; 53(8): 2095 - 2100. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. E. Goldstein, R. R. Little, R. A. Lorenz, J. I. Malone, D. Nathan, C. M. Peterson, and D. B. Sacks Tests of Glycemia in Diabetes Diabetes Care, July 1, 2004; 27(7): 1761 - 1773. [Full Text] [PDF]
|
|
|
|
|
|
J. B. Meigs, K. Williams, L. M. Sullivan, K. J. Hunt, S. M. Haffner, M. P. Stern, C. Gonzalez Villalpando, J. S. Perhanidis, D. M. Nathan, R. B. D'Agostino Jr, et al. Using Metabolic Syndrome Traits for Efficient Detection of Impaired Glucose Tolerance Diabetes Care, June 1, 2004; 27(6): 1417 - 1426. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. B. Meigs, P. W.F. Wilson, D. M. Nathan, R. B. D'Agostino Sr., K. Williams, and S. M. Haffner Prevalence and Characteristics of the Metabolic Syndrome in the San Antonio Heart and Framingham Offspring Studies Diabetes, August 1, 2003; 52(8): 2160 - 2167. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. R. Carnethon, S. H. Golden, A. R. Folsom, W. Haskell, and D. Liao Prospective Investigation of Autonomic Nervous System Function and the Development of Type 2 Diabetes: The Atherosclerosis Risk In Communities Study, 1987-1998 Circulation, May 6, 2003; 107(17): 2190 - 2195. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. H. Saydah, E. A. Platz, N. Rifai, M. N. Pollak, F. L. Brancati, and K. J. Helzlsouer Association of Markers of Insulin and Glucose Control with Subsequent Colorectal Cancer Risk Cancer Epidemiol. Biomarkers Prev., May 1, 2003; 12(5): 412 - 418. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. M. Alexander, P. B. Landsman, S. M. Teutsch, and S. M. Haffner NCEP-Defined Metabolic Syndrome, Diabetes, and Prevalence of Coronary Heart Disease Among NHANES III Participants Age 50 Years and Older Diabetes, May 1, 2003; 52(5): 1210 - 1214. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Harris, K. Donahue, S. S. Rathore, P. Frame, S. H. Woolf, and K. N. Lohr Screening Adults for Type 2 Diabetes: A Review of the Evidence for the U.S. Preventive Services Task Force Ann Intern Med, February 4, 2003; 138(3): 215 - 229. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
References Circulation, December 17, 2002; 106(25): 3373 - 3421. [Full Text]
|
|
|
|
|
|
H. B. Rubins, S. J. Robins, D. Collins, D. B. Nelson, M. B. Elam, E. J. Schaefer, F. H. Faas, J. W. Anderson, and for the VA-HIT Study Group Diabetes, Plasma Insulin, and Cardiovascular Disease: Subgroup Analysis From the Department of Veterans Affairs High-Density Lipoprotein Intervention Trial (VA-HIT) Arch Intern Med, December 9, 2002; 162(22): 2597 - 2604. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R G. Barr, D. M. Nathan, J. B. Meigs, and D. E. Singer Tests of Glycemia for the Diagnosis of Type 2 Diabetes Mellitus Ann Intern Med, August 20, 2002; 137(4): 263 - 272. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. B. Meigs, M. G. Larson, R. B. D'Agostino, D. Levy, M. E. Clouse, D. M. Nathan, P. W. F. Wilson, and C. J. O'Donnell Coronary Artery Calcification in Type 2 Diabetes and Insulin Resistance: The Framingham Offspring Study Diabetes Care, August 1, 2002; 25(8): 1313 - 1319. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. B. Meigs, R. B. D'Agostino Sr., D. M. Nathan, N. Rifai, and P. W.F. Wilson Longitudinal Association of Glycemia and Microalbuminuria: The Framingham Offspring Study Diabetes Care, June 1, 2002; 25(6): 977 - 983. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. B. Meigs, C. I. M. Panhuysen, R. H. Myers, P. W.F. Wilson, and L. A. Cupples A Genome-Wide Scan for Loci Linked to Plasma Levels of Glucose and HbA1c in a Community-Based Sample of Caucasian Pedigrees: The Framingham Offspring Study Diabetes, March 1, 2002; 51(3): 833 - 840. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. H. Saydah, M. Miret, J. Sung, C. Varas, D. Gause, and F. L. Brancati Postchallenge Hyperglycemia and Mortality in a National Sample of U.S. Adults Diabetes Care, August 1, 2001; 24(8): 1397 - 1402. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. R. Galluzzi, L. A. Cupples, J. B. Meigs, P. W.F. Wilson, E. J. Schaefer, and J. M. Ordovas Association of the Ala54-thr Polymorphism in the Intestinal Fatty Acid-Binding Protein With 2-h Postchallenge Insulin Levels in the Framingham Offspring Study Diabetes Care, July 1, 2001; 24(7): 1161 - 1166. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. J.G. Hanley, G. McKeown-Eyssen, S. B. Harris, R. A. Hegele, T. M.S. Wolever, J. Kwan, P. W. Connelly, and B. Zinman Cross-Sectional and Prospective Associations Between Proinsulin and Cardiovascular Disease Risk Factors in a Population Experiencing Rapid Cultural Transition Diabetes Care, July 1, 2001; 24(7): 1240 - 1247. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. A. Matthews, L. H. Kuller, K. Sutton-Tyrrell, Y.-F. Chang, G. E. Tietjen, and R. L. Brey Changes in Cardiovascular Risk Factors During the Perimenopause and Postmenopause and Carotid Artery Atherosclerosis in Healthy Women Editorial Comment : Premenopausal Risk Continuum for Carotid Atherosclerosis After Menopause Stroke, May 1, 2001; 32(5): 1104 - 1111. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. J. Freeman, J. Norrie, N. Sattar, R. D. G. Neely, S. M. Cobbe, I. Ford, C. Isles, A. R. Lorimer, P. W. Macfarlane, J. H. McKillop, et al. Pravastatin and the Development of Diabetes Mellitus : Evidence for a Protective Treatment Effect in the West of Scotland Coronary Prevention Study Circulation, January 23, 2001; 103(3): 357 - 362. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Levetan Diabetes Prevention: How About NOW? Clin. Diabetes, January 1, 2001; 19(1): 34 - 38. [Full Text] [PDF]
|
|
|
|
|
|
M. Shechter, C. N. Bairey Merz, M. J. Paul-Labrador, and S. Kaul Blood glucose and platelet-dependent thrombosis in patients with coronary artery disease J. Am. Coll. Cardiol., February 1, 2000; 35(2): 300 - 307. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. M. Haffner, C. M. Alexander, T. J. Cook, S. J. Boccuzzi, T. A. Musliner, T. R. Pedersen, J. Kjekshus, K. Pyorala, and for the Scandinavian Simvastatin Survival Study Gr Reduced Coronary Events in Simvastatin-Treated Patients With Coronary Heart Disease and Diabetes or Impaired Fasting Glucose Levels: Subgroup Analyses in the Scandinavian Simvastatin Survival Study Arch Intern Med, December 13, 1999; 159(22): 2661 - 2667. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. E. Schoen, C. M. Tangen, L. H. Kuller, G. L. Burke, M. Cushman, R. P. Tracy, A. Dobs, and P. J. Savage Increased Blood Glucose and Insulin, Body Size, and Incident Colorectal Cancer J Natl Cancer Inst, July 7, 1999; 91(13): 1147 - 1154. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. H. Davidson, J. Hauptman, M. DiGirolamo, J. P. Foreyt, C. H. Halsted, D. Heber, D. C. Heimburger, C. P. Lucas, D. C. Robbins, J. Chung, et al. Weight Control and Risk Factor Reduction in Obese Subjects Treated for 2 Years With Orlistat: A Randomized Controlled Trial JAMA, January 20, 1999; 281(3): 235 - 242. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Glucose Intolerance and Syndrome X: Common and Continuous Risk Factors Journal Watch Cardiology, April 30, 1998; 1998(430): 4 - 4. [Full Text]
|
|
Article
